Why Should You Retain CME Group (CME) In Your Portfolio

 | Aug 17, 2017 10:22PM ET

Shares of CME Group Inc. (NASDAQ:CME) have outperformed the industry , quarter to date. The company also witnessed estimate revisions over the past 30 days. This Zacks Rank #3 (Hold) securities exchange is high on potential, driven by a few good growth drivers.

Positive Growth Projections: The Zacks Consensus Estimate for earnings is $4.81 for 2017, reflecting year-over-year growth of 6.28%. For 2018, the Zacks Consensus Estimate for earnings is pegged at $5.27, representing 9.41% year-over-year growth.

CME Group has long-term expected earnings per share growth of 10.6%.

An Outperformer: CME Group shares have rallied 18.4% in a year’s time, outperforming the industry’s 18.0% growth. Shares have also outperformed the S&P 500, increasing 11.0% over the same time frame.